Thank you for visiting my personal page!
I was diagnosed with stage three multiple myeloma in June of 2016. Following four months of induction chemotherapy at Texas Oncology Dallas, I underwent an autologous stem cell transplant at UT Southwestern Medical Center (Clements University Hospital). Through the efforts of my oncology teams and the ongoing support of family/friends/colleagues, I have remained in complete remission since November 2016.
Multiple myeloma is a blood cancer that affects the plasma cells in the bone marrow. Historically, there was little hope for multiple myeloma patients due to incredibly limited treatment options. While still considered incurable and terminal, new innovative therapies approved during the past decade have been made available for patients. Multiple myeloma experts currently estimate the average survival rate is now 8 - 10 years. Lives are being extended and hope for a cure is now becoming a reality.
* In 2017 an estimated 30,280 new cases of multiple myeloma will be
diagnosed representing 1.8% of all new cancer cases.
* Approximately 12,950 deaths are expected from the disease in 2017.
* In Texas, approximately 1,987 new cases will be diagnosed and an
estimated 891 people will die from the disease in 2017.
This year, I will be participating in the Multiple Myeloma Research Foundation (MMRF) Team for Cures 5K Walk/Run in Dallas, Texas. The mission of the MMRF is to relentlessly pursue innovative means that accelerate the development of next-generation multiple myeloma treatments to extend the lives of patients and ultimately lead to a cure.
As the world's number-one private funder of multiple myeloma research, the MMRF has raised over $330 million since its inception and directs 90% of total budget to research and related programming. The MMRF is a pioneer in breaking down existing barriers to traditional cancer research. The MMRF is the only cancer research organization that has built an end-to-end precision cancer research system to facilitate the entire research process. The MMRF research system unites academia, biotechs, clinics, researchers, the FDA, the NIH, caregivers and patients. Now considered the most effective approach in cancer research today, the MMRF is literally changing the way cancer research is conducted.
Your donation will have a meaningful impact on the lives of thousands of patients and their families! This event will raise funds that have helped:
*Triple patient survival rates
*Deliver ten new treatments in a decade
*Conduct over 60 phase I and phase II clinical trials
PLEASE JOIN ME AND BE PART OF A TEAM THAT IS CURING CANCER NOW!
* Double your impact! Many employers sponsor matching gift programs and will match charitable contributions made by their employees.